2014
DOI: 10.1038/modpathol.2013.191
|View full text |Cite
|
Sign up to set email alerts
|

Bone marrow involvement by subcutaneous Panniculitis-like T-cell lymphoma: a report of three cases

Abstract: Subcutaneous panniculitis-like T-cell lymphoma is a rare subtype of cutaneous T-cell lymphoma. Virtually all cases are confined to the subcutaneous adipose tissue. In this report, we describe the first small series of subcutaneous panniculitis-like T-cell lymphoma (three patients) with bone marrow involvement. All patients presented with skin or soft tissue nodules, fever, and constitutional symptoms, and were diagnosed with subcutaneous panniculitis-like T-cell lymphoma based on the characteristic morphologic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
8
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(9 citation statements)
references
References 9 publications
1
8
0
Order By: Relevance
“…Even in cases treated with combination chemotherapies, 4 cases were refractory to the firstline chemotherapies, experienced recurrence or died within 2 months after diagnosis (4)(5)(6)8). Prolonged etoposide monotherapy resulted in long-term remission in our case following a relapse episode after CHOP therapy, while 3 cases were previously reported to experience recurrence after combination chemotherapies including etoposide (5,6,8). Chronic daily oral low-dose etoposide therapy is re-portedly effective in refractory lymphoma (13).…”
Section: Discussionmentioning
confidence: 64%
“…Even in cases treated with combination chemotherapies, 4 cases were refractory to the firstline chemotherapies, experienced recurrence or died within 2 months after diagnosis (4)(5)(6)8). Prolonged etoposide monotherapy resulted in long-term remission in our case following a relapse episode after CHOP therapy, while 3 cases were previously reported to experience recurrence after combination chemotherapies including etoposide (5,6,8). Chronic daily oral low-dose etoposide therapy is re-portedly effective in refractory lymphoma (13).…”
Section: Discussionmentioning
confidence: 64%
“…Morphologic and immunophenotypic evidence of bone marrow involvement by SPTCL has only recently been described in three patients. 13 All patients had concurrent skin lesions meeting current diagnostic criteria for SPTCL. Bone marrow biopsy specimens showed focal involvement by cytologically atypical lymphocytes that expressed CD3 and CD8 and rimmed individual adipocytes.…”
Section: Discussionmentioning
confidence: 99%
“…3,5,6 Morphologic bone marrow involvement by the neoplastic cells of SPTCL has only recently been described in three patients. 13 Previously, bone marrow examination in patients with SPTCL has been significant only for hemophagocytosis. 3,8,9,12 Autopsies performed on five patients with SPTCL and fatal hemophagocytic syndrome showed no evidence of dissemination to nonsubcutaneous sites; lymph nodes, liver, and bone marrow revealed evidence only of hemophagocytosis.…”
mentioning
confidence: 99%
“…An astute histopathologist can make the distinction based on histopathology, immunophenotyping, and clonal TCR gene rearrangement. Bone marrow involvement in SPTL is rare [7][8][9]. Features such as splenomegaly, pancytopenia, elevated lactate dehydrogenase, ferritin, and triglycerides are manifested in HS, while PAN is usually accompanied by anemia, thrombocytosis, and elevated acute phase reactants (erythrocyte sedimentation rate and Creactive protein).…”
Section: Discussionmentioning
confidence: 99%